Raipur, Oct. 11, 2022 (GLOBE NEWSWIRE) -- Stratview Research, a leading market research firm has launched a report on the Multiple Sclerosis Therapeutics Market which provides an in-depth analysis of the market dynamics, current and emerging trends, industry forecast, and competitive landscape.
Click here to get the free sample pdf:
How is the Report Helpful?
The report has a very high utility for the key decision-makers and strategists in terms of accurate market insights, future growth opportunities, and key success factors.
Most importantly, the report analyses the possible impact of COVID-19 on the market dynamics which offers cushioning against the uncertain business environment and helps in streamlining the resources and investment decisions in a fruitful manner.
What are the Top Market Drivers?
According to the report, the Multiple Sclerosis Therapeutics Market is driven by a host of factors, some of which are noted below:
- The rising number of people suffering from relapsing-remitting and secondary progressive multiple sclerosis.
- The increasing prevalence of chronic diseases due to changing lifestyle and stress.
- The rising demand for novel drug development to treat multiple sclerosis.
The report also includes growth rate estimates based upon the intensity of drivers and constraints and provides the users with several graphical illustrations of the key insights.
Multiple Sclerosis Therapeutics Market Segmentation:
Stratview Research has segmented the market in the following ways which fulfill the market data needs of multiple stakeholders across the industry value chain.
- By Drug Type (Immunomodulators, Immunosuppressant, Copaxone, Avonex, Gilenya, Other),
- By Mode of Administration Type (Oral, Injectable, Intravenous),
- By Distribution Channel Type (Hospital Pharmacies, Retail Pharmacies, e-Commerce),
- By Region (North America, Europe, Asia-Pacific, and Rest of the World).
Multiple Sclerosis Therapeutics Market Insights
Market Trends by Distribution Channel Type
The multiple sclerosis therapeutics markets have been bifurcated into hospital pharmacies, retail pharmacies, and e-commerce. The hospital pharmacies segment accounted for the largest market share in 2021 and is projected to register significant growth during the review period. The segment growth can be attributed to convenience and easy availability of required drugs at hospital pharmacies.
Which region offers the best opportunity and growth?
The North American market accounted for the largest market share in 2021 and is projected to grow at a robust CAGR during the review period. This can be attributed to the established presence of the healthcare industry coupled with the presence of key market players such as Sanofi Genzyme (US) and Pfizer Inc. (US). The market growth in Asia-Pacific is expected to be driven by an increasing number of people suffering from chronic diseases.
COVID-19 Impact on the Multiple Sclerosis Therapeutics Market
COVID-19 has put an instant halt to many industries across the globe. Lockdown norms in several countries have swiftly affected the global economy by affecting the supply chain, production, and demand in the market. Both direct, as well as indirect impacts of the pandemic, have been incorporated in this report.
To know more about the covid-19 impact, get a free sample report, here:
Who are the Top Market Players?
After a thorough analysis of the market, the experts have listed a few key players and discussed company profiles of the below-given players -
- Novartis International AG (Switzerland)
- Teva Pharmaceutical Industries Ltd. (Israel)
- Sanofi Genzyme (US)
- Bayer AG (Germany)
- Pfizer Inc. (US)
- Biogen Inc. (US)
- The Merck Group (Germany)
- AbbVie (US).
What deliverables will you get in this report?
- In-depth analysis of the Multiple Sclerosis Therapeutics Market
- Detailed market segmentation.
- Competitive-landscape analysis.
- Historical, present, and future market size analysis.
- Industry trends, technologies, and advancements.
- Growth and operation strategies adopted by key players.
- Potential segments/regions offering promising growth.
- Geographical presence of the key players.
Related reports which might be useful:
- Hypertrophic Cardiomyopathy (HCM) Therapeutics Market
https://www.stratviewresearch.com/2653/hypertrophic-cardiomyopathy-HCM-therapeutics-market.html
- Hemophilia A and B Therapeutics Materials Market
https://www.stratviewresearch.com/2366/Hemophilia-A-and-B-Therapeutics-Materials-Market.html
About us –
Stratview Research is a global market research firm that offers reliable market reports, market entry strategies, strategic growth consulting, and more. The market experts compile high-quality market information to help users obtain granular level clarity on current business trends and expected future developments. Stratview Research also offers customisation of the reports. Reach out to the analysts to customize the given report according to your priority/requirement.
Stratview Research has also launched 'Composights', an online portal that offers free thought leadership reports, whitepapers, market report synopsis, and much more for Composites and allied industries, worth US$ 20,000 every year.
Click here to sign up (No costs involved):
https://www.stratviewresearch.com/composights/sign-in
